See more : Mostostal Warszawa S.A. (MSW.WA) Income Statement Analysis – Financial Results
Complete financial analysis of Create Medic Co., Ltd. (5187.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Create Medic Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Dubai Electricity and Water Authority (PJSC) (DEWA.AE) Income Statement Analysis – Financial Results
- Grupo Security S.A. (SECURITY.SN) Income Statement Analysis – Financial Results
- PHAXIAM Therapeutics S.A. (PHXM) Income Statement Analysis – Financial Results
- Grindrod Shipping Holdings Ltd. (GRIN) Income Statement Analysis – Financial Results
- Galderma Group N (GALD.SW) Income Statement Analysis – Financial Results
Create Medic Co., Ltd. (5187.T)
About Create Medic Co., Ltd.
Create Medic Co., Ltd. researches, develops, manufactures, and sells medical appliances in Japan and internationally. The company offers disposable medical devices made of silicone resin. It provides various urology, gastroenterology, percutaneous endoscopic gastrostomy, and surgery products. The company also provides other products, such as CLINY tracheostomy tubes, endotracheal tubes, tracheostomy tubes, and microcatheters. In addition, it offers OEM products comprising multi-lumen tubes, ultrathin walls, profile extrusions, and special structures; special shape and high-volume low-pressure cuff moldings; and hydrophilic coating and needles, as well as the technology on an OEM basis. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.59B | 12.26B | 11.70B | 10.83B | 10.84B | 10.80B | 10.39B | 10.00B | 9.65B | 9.94B | 9.88B | 9.33B | 9.33B | 9.10B | 9.02B | 9.06B |
| Cost of Revenue | 7.11B | 6.88B | 6.44B | 5.75B | 5.62B | 5.75B | 5.47B | 5.50B | 5.44B | 5.68B | 5.50B | 5.03B | 4.82B | 4.48B | 4.41B | 4.36B |
| Gross Profit | 5.48B | 5.37B | 5.26B | 5.08B | 5.23B | 5.04B | 4.92B | 4.50B | 4.21B | 4.26B | 4.38B | 4.31B | 4.50B | 4.61B | 4.60B | 4.70B |
| Gross Profit Ratio | 43.53% | 43.85% | 44.96% | 46.88% | 48.21% | 46.72% | 47.36% | 45.02% | 43.64% | 42.81% | 44.31% | 46.14% | 48.29% | 50.71% | 51.05% | 51.88% |
| Research & Development | 850.00M | 882.09M | 785.74M | 630.24M | 637.20M | 616.61M | 506.15M | 362.92M | 281.33M | 250.00M | 285.00M | 358.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.82B | 3.75B | 3.61B | 3.46B | 3.51B | 3.43B | 3.56B | 3.39B | 3.28B | 3.47B | 3.55B | 3.57B | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 4.64B | 4.39B | 4.09B | 4.14B | 12.58M | 18.10M | 13.04M | 15.85M | 13.86M | 23.55M | 52.38M | 2.54M | 16.63M | 7.59M | 33.81M |
| Operating Expenses | 4.68B | 4.64B | 4.39B | 4.09B | 4.14B | 4.05B | 4.07B | 3.75B | 3.56B | 3.47B | 3.55B | 3.57B | 3.50B | 3.38B | 3.33B | 3.27B |
| Cost & Expenses | 11.78B | 11.52B | 10.83B | 9.85B | 9.76B | 9.80B | 9.54B | 9.25B | 9.00B | 9.16B | 9.06B | 8.59B | 8.32B | 7.87B | 7.74B | 7.63B |
| Interest Income | 29.04M | 35.86M | 37.44M | 27.38M | 20.61M | 14.27M | 21.38M | 16.94M | 20.21M | 24.94M | 14.62M | 9.64M | 5.69M | 4.02M | 5.04M | 10.23M |
| Interest Expense | 10.98M | 7.08M | 6.10M | 7.31M | 8.00M | 6.90M | 9.92M | 12.48M | 12.05M | 13.08M | 15.16M | 17.50M | 14.17M | 16.60M | 19.39M | 19.46M |
| Depreciation & Amortization | 588.15M | 604.84M | 462.47M | 405.88M | 389.96M | 348.77M | 348.57M | 332.48M | 319.93M | 349.29M | 306.25M | 273.77M | 238.77M | 226.53M | 267.78M | 290.56M |
| EBITDA | 1.50B | 1.47B | 1.43B | 1.40B | 1.50B | 1.34B | 1.13B | 1.15B | 951.24M | 1.19B | 1.22B | 1.21B | 1.31B | 1.36B | 1.39B | 1.62B |
| EBITDA Ratio | 11.94% | 11.57% | 12.69% | 12.67% | 13.51% | 12.50% | 11.94% | 11.66% | 10.23% | 13.73% | 12.90% | 12.98% | 13.22% | 14.88% | 16.87% | 17.90% |
| Operating Income | 803.24M | 737.71M | 866.78M | 984.82M | 1.08B | 993.86M | 854.01M | 754.28M | 648.16M | 784.23M | 824.65M | 739.77M | 1.00B | 1.23B | 1.28B | 1.43B |
| Operating Income Ratio | 6.38% | 6.02% | 7.41% | 9.09% | 9.99% | 9.20% | 8.22% | 7.54% | 6.72% | 7.89% | 8.35% | 7.93% | 10.74% | 13.53% | 14.16% | 15.82% |
| Total Other Income/Expenses | 100.78M | 95.73M | 98.84M | -432.00K | 18.15M | -13.69M | -84.61M | 53.17M | -28.90M | 43.26M | 70.22M | 178.73M | 51.05M | -116.33M | -175.28M | -118.61M |
| Income Before Tax | 904.02M | 836.74M | 965.63M | 984.39M | 1.10B | 980.17M | 769.40M | 807.44M | 619.26M | 827.49M | 894.87M | 918.50M | 1.05B | 1.11B | 1.10B | 1.31B |
| Income Before Tax Ratio | 7.18% | 6.83% | 8.25% | 9.09% | 10.16% | 9.08% | 7.40% | 8.07% | 6.42% | 8.32% | 9.06% | 9.84% | 11.28% | 12.25% | 12.22% | 14.52% |
| Income Tax Expense | 750.00M | 376.10M | 305.22M | 324.87M | 376.53M | 307.63M | 301.43M | 290.75M | 286.11M | 337.43M | 361.24M | 406.23M | 468.98M | 447.25M | 476.47M | 504.63M |
| Net Income | 154.02M | 482.21M | 660.41M | 659.52M | 725.05M | 672.54M | 467.96M | 516.70M | 333.14M | 490.06M | 533.63M | 512.27M | 583.38M | 667.54M | 625.50M | 810.33M |
| Net Income Ratio | 1.22% | 3.93% | 5.65% | 6.09% | 6.69% | 6.23% | 4.50% | 5.17% | 3.45% | 4.93% | 5.40% | 5.49% | 6.26% | 7.34% | 6.94% | 8.95% |
| EPS | 16.92 | 53.00 | 72.61 | 71.19 | 77.83 | 72.20 | 50.23 | 54.73 | 34.64 | 50.96 | 55.49 | 53.27 | 60.66 | 69.41 | 65.04 | 84.26 |
| EPS Diluted | 16.92 | 53.00 | 72.61 | 71.19 | 77.83 | 72.20 | 50.23 | 54.73 | 34.64 | 50.96 | 55.49 | 53.27 | 60.66 | 69.41 | 65.04 | 84.26 |
| Weighted Avg Shares Out | 9.10M | 9.10M | 9.09M | 9.26M | 9.32M | 9.32M | 9.32M | 9.44M | 9.62M | 9.62M | 9.62M | 9.62M | 9.62M | 9.62M | 9.62M | 9.62M |
| Weighted Avg Shares Out (Dil) | 9.10M | 9.10M | 9.09M | 9.26M | 9.32M | 9.32M | 9.32M | 9.44M | 9.62M | 9.62M | 9.62M | 9.62M | 9.62M | 9.62M | 9.62M | 9.62M |
Source: https://incomestatements.info
Category: Stock Reports